Vanguard Group Inc Second Sight Medical Products Inc Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.0 - $4.48 $0 - $4.02 Million	-897,358 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$1.22 - $2.57 $395,702 - $833,569	-324,346 Reduced 26.55%	897,358 $1.82 Million
Q1 2022 May 13, 2022	BUY	$1.16 - $1.83 $19,910 - $31,410	17,164 Added 1.42%	1,221,704 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.41 $59,964 - $125,447	36,788 Added 3.15%	1,204,540 $1.96 Million
Q3 2021 Nov 12, 2021	BUY	$3.11 - $4.75 $16,778 - $25,626	5,395 Added 0.46%	1,167,752 $3.73 Million

Q2 2021 Aug 13, 2021	BUY	$4.94 - $9.43 $5.74 Million - $11 Million	1,162,357 New	1,162,357 $5.74 Million

Ticker EYES
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,136,400
Market Cap $54.4M
Description
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.